Results 141 to 150 of about 1,402,994 (298)

Rainbow Wash or Rainbow Revolution? Dynamic Stakeholder Engagement for SDG-Driven Responsible Innovation. [PDF]

J Bus Ethics, 2022
Gutierrez L, Montiel I, Surroca JA, Tribo JA.   +3 more
europepmc   +1 more source

Response to Allopurinol and Febuxostat According to the Fractional Excretion of Urate in Men With Gout

Arthritis Care &Research, EarlyView.
Objective Body mass index (BMI), glomerular filtration rate (GFR), and pretreatment urate levels have been reported to influence the urate‐lowering response to allopurinol. We investigated whether the fractional excretion of uric acid (FEUA) also modulates this response and relates to oxypurinol concentrations.
Pascal Richette, Anouk Walter‐Petrich, Quang Dinh Nguyen, Matthieu Resche‐Rigon, Quang Huy Dinh Nguyen, Minh Duc Do, Thao Phuong Mai, Tuan Duc Nguyen, Fernando Perez‐Ruiz, Emmanuel Letavernier, Tristan Pascart, Augustin Latourte, Hang Korng Ea, Thomas Bardin   +13 more
wiley   +1 more source

Navigating the complexities of AI and digital governance: the 5W1H framework

Journal of Responsible Technology
As AI and digital technologies advance rapidly, governance frameworks struggle to keep pace with emerging applications and risks. This paper introduces a ''5W1H'' framework to systematically analyze AI governance proposals through six key questions: What
S. Matthew Liao, Iskandar Haykel, Katherine Cheung, Taylor Matalon   +3 more
doaj   +1 more source

Combining development, capacity building and responsible innovation in GCRF-funded medical technology research. [PDF]

Dev World Bioeth, 2022
Bezuidenhout L, Stirling J, Sanga VL, Nyakyi PT, Mwakajinga GA, Bowman R.   +5 more
europepmc   +1 more source

Towards a dialogic management of cognitive competence [PDF]

In this paper we examine the nature of the competences needed for promoting innovation and change. Taking our experiences as the starting point, we examined the literature and interviewed managers and those responsible for innovation in enterprises and ...
Aline Dupouy, Jean Michel Larrasquet, Nimal Jayaratna, Véronique Pilnière   +3 more
core  

A theoretical model for design in Management science : the paradigm shift in the design profession for management as a constraint to management science as an opportunity [PDF]

, 2008
Design Management has changed greatly since 1990 Peter Gorb definition .The purpose of this paper is to synthetize the various models of Design Management and to explain their limits in front of the paradigm shift of the design profession, changing “from
Borja de Mozota, B
core  

Validation of a Genetic Risk Score Combined With Clinical Variables for Predicting Pulmonary Fibrosis in Early Rheumatoid Arthritis

Arthritis Care &Research, EarlyView.
Objective Pulmonary fibrosis (PF) is a severe extra‐articular manifestation of rheumatoid arthritis (RA). This study aimed to externally validate a genetic risk score (GRS) and a combined risk score (CRS) for predicting the risk of RA‐associated PF in an independent cohort of patients with early RA.
Mikael Brink, Austin Wheeler, Bryant R. England, Solbritt Rantapää‐Dahlqvist   +3 more
wiley   +1 more source

Responsible innovation in health and health system sustainability: Insights from health innovators' views and practices. [PDF]

Health Serv Manage Res, 2022
Lehoux P, Silva HP, Rocha de Oliveira R, Sabio RP, Malas K.   +4 more
europepmc   +1 more source

Performance Characteristics of Anti–Collagen II Antibodies in Relapsing Polychondritis and Related Diseases: Prospective Analysis, Systematic Review, and Meta‐Analysis

Arthritis Care &Research, EarlyView.
Objective Relapsing polychondritis (RP) is a rare disease defined by recurrent cartilaginous inflammation. Anti–collagen II (Col2) antibodies have been proposed as a diagnostic biomarker for RP, but their performance characteristics are not well defined.
Karyssa Stonick, Marcela A. Ferrada, Alice Fike, Kaitlin A. Quinn, Benjamin A. Turturice, Casey Stein, Peter C Grayson   +6 more
wiley   +1 more source

Fostering Responsible Innovation in Health: An Evidence-Informed Assessment Tool for Innovation Stakeholders. [PDF]

Int J Health Policy Manag, 2021
Silva HP, Lefebvre AA, Oliveira RR, Lehoux P.   +3 more
europepmc   +1 more source